"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development Overview
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEW
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEW
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEW
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MORE
"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESThe In Vitro Diagnostics (IVD) market is undergoing significant transformation, driven by technological advancements, shifting market dynamics, and evolving regulatory landscapes. As we navigate through 2024, the IVD sector continues to rebound from the disruptions caused by the COVID-19 pandemic, with a notable 6% growth in 2023, a clear sign of recovery and expansion.
This growth was fueled by improvements in capital purchasing, the expansion of assay menus, automation solutions, and the broadening of care settings to include pharmacy channels and at-home testing. Despite a decline in COVID-19 related sales, the core IVD market remains robust, with significant gains in core lab and Point-of-Care (POC) segments.
Regionally, the market dynamics are varied. While all regions experienced declines due to reduced COVID-19 sales, the underlying business for many players showed positive trends. Emerging markets are poised for growth, driven by a large, underpenetrated patient base, increased diagnosis rates, and heightened awareness.
Leading companies such as Roche, Mindray, and Sysmex experienced the highest percentage across key core laboratory markets. These companies along with other major players such as Siemens, Abbott, BioMerieux and others are setting the pace in the industry, demonstrating the importance of innovation and strategic market positioning.
Looking ahead, several factors will drive the IVD market. Increased regulation, such as FDA/IVDR, favors multinational corporations with substantial resources and experience. The shift towards POC testing and the expansion of precision medicine beyond oncology to other high-burden areas are expected to be significant growth drivers. Additionally, digital pathology, IT, and AI solutions are anticipated to enhance diagnostic efficiency and accuracy.
However, the industry faces several challenges. Navigating the complex regulatory landscape requires substantial resources and expertise, posing a significant barrier for smaller companies. The competitive nature of the market, with major players continuously expanding their product portfolios and technological capabilities, could lead to market saturation. Integrating advanced technologies such as AI and digital diagnostics into existing workflows also presents challenges, particularly in ensuring interoperability and data security.
The IVD market is poised for continued growth, driven by technological advancements, and increasing healthcare demands. By addressing regulatory challenges, investing in innovation, and leveraging digital technologies, the MedTech industry can navigate the evolving landscape and continue to deliver impactful diagnostic solutions.
To go deeper on the future of the IVD market, join industry experts on October 24, 2024, for our Global IVD Market Review Webinar. Register Now!
Forging a path for MedTech Innovation.
